GlassScriptPhysician profile
Kelly Hacker
NPI 1104090208
$909.26
in general payments reported to CMS, 2019-2025
16 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.71 · 2022: $62.41 · 2023: $215 · 2024: $251 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $313.33 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $91.64 | 2021-2024 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.55 | 2023-2025 | Lifevest |
| Esperion Therapeutics, INC. | $59.74 | 2024-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $57.56 | 2023 | Assure Wcd |
| Merck Sharp & Dohme LLC | $52.41 | 2024 | Winrevair |
| Edwards Lifesciences Corporation | $44.84 | 2024-2025 | Evoque, Pascal |
| Actelion Pharmaceuticals US, INC. | $34.06 | 2022-2023 | Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.14 | 2023 | Jardiance |
| Medtronic, INC. | $30.75 | 2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $25.16 | 2025 | |
| Novo Nordisk INC | $23.27 | 2025 | Ozempic |
| Chiesi USA, INC. | $19.32 | 2023 | Cleviprex, Kengreal |
| Alnylam Pharmaceuticals INC. | $18.62 | 2024 | Onpattro |
| Recor Medical INC | $15.56 | 2024 | Paradise Renal Denervation System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Hacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.